pioglitazone has been researched along with Impotence in 5 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of pioglitazone on sildenafil responsiveness in men with erectile dysfunction(ED) and a history of poor response to sildenafil were assessed." | 9.13 | Effects of pioglitazone on erectile dysfunction in sildenafil poor-responders: a randomized, controlled study. ( Gholamine, B; Mahmoudian, M; Motevallian, M; Shafiei, M, 2008) |
| "The effects of pioglitazone on sildenafil responsiveness in men with erectile dysfunction(ED) and a history of poor response to sildenafil were assessed." | 5.13 | Effects of pioglitazone on erectile dysfunction in sildenafil poor-responders: a randomized, controlled study. ( Gholamine, B; Mahmoudian, M; Motevallian, M; Shafiei, M, 2008) |
| "To examine the effect of pioglitazone on erectile function in a rat model of postprostatectomy erectile dysfunction." | 3.80 | Efficacy of pioglitazone on erectile function recovery in a rat model of cavernous nerve injury. ( Aliperti, LA; Gokce, A; Hagan, SS; Hellstrom, JA; Hellstrom, WJ; Kadowitz, PJ; Lasker, GF; Sikka, SC; Trost, LW, 2014) |
| "Pioglitazone is an anti-diabetic agent with recognized antifibrotic and vasculoprotective properties, which can protect smooth muscle function." | 1.40 | Pioglitazone prevents cavernosal nerve injury after radical prostatectomy. ( Aliperti, LA; Hellstrom, WJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heidenberg, DJ | 1 |
| Haney, NM | 1 |
| Rezk, BM | 1 |
| Talwar, S | 1 |
| Okpechi, SC | 1 |
| Srivastav, SK | 1 |
| Honda, M | 1 |
| Song, B | 1 |
| Swan, K | 1 |
| Awadallah, S | 1 |
| Anaissie, J | 1 |
| Peak, T | 1 |
| DeLay, KJ | 1 |
| Kadowitz, PJ | 2 |
| Sikka, SC | 2 |
| Abdel Mageed, AB | 1 |
| Hellstrom, WJG | 1 |
| Weyne, E | 1 |
| Aliperti, LA | 2 |
| Hellstrom, WJ | 2 |
| Lasker, GF | 1 |
| Hagan, SS | 1 |
| Hellstrom, JA | 1 |
| Gokce, A | 1 |
| Trost, LW | 1 |
| Gholamine, B | 1 |
| Shafiei, M | 1 |
| Motevallian, M | 1 |
| Mahmoudian, M | 1 |
1 trial available for pioglitazone and Impotence
| Article | Year |
|---|---|
Effects of pioglitazone on erectile dysfunction in sildenafil poor-responders: a randomized, controlled study.
Topics: Adult; Aged; Double-Blind Method; Drug Synergism; Erectile Dysfunction; Humans; Male; Middle Aged; P | 2008 |
4 other studies available for pioglitazone and Impotence
| Article | Year |
|---|---|
Pioglitazone's beneficial effects on erectile function preservation after cavernosal nerve injury in the rat are negated by inhibition of the insulin-like growth factor-1 receptor: a preclinical study.
Topics: Animals; Erectile Dysfunction; Male; Nerve Crush; Nitric Oxide Synthase Type I; Penile Erection; Per | 2019 |
A sugar sweet new treatment for erectile dysfunction after radical prostatectomy.
Topics: Animals; Erectile Dysfunction; Humans; Insulin-Like Growth Factor I; Male; Pioglitazone; Prostatecto | 2019 |
Pioglitazone prevents cavernosal nerve injury after radical prostatectomy.
Topics: Erectile Dysfunction; Fibrosis; Humans; Male; Models, Theoretical; Muscle, Smooth; Penis; Pioglitazo | 2014 |
Efficacy of pioglitazone on erectile function recovery in a rat model of cavernous nerve injury.
Topics: Animals; Arterial Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Er | 2014 |